S&P 500   3,941.67 (-0.40%)
DOW   33,612.22 (-0.71%)
QQQ   280.91 (+0.12%)
AAPL   141.18 (+0.01%)
MSFT   242.00 (+0.69%)
META   111.56 (+1.92%)
GOOGL   96.13 (+0.99%)
AMZN   91.85 (-0.62%)
TSLA   181.45 (+0.34%)
NVDA   157.60 (+0.77%)
NIO   12.25 (+16.67%)
BABA   87.02 (+8.97%)
AMD   73.11 (-0.38%)
T   18.94 (-0.37%)
MU   54.48 (-1.16%)
CGC   3.43 (+0.29%)
F   13.55 (-1.45%)
GE   83.53 (-2.49%)
DIS   94.32 (-0.39%)
AMC   7.11 (-4.31%)
PYPL   75.79 (-2.38%)
PFE   49.28 (-0.42%)
NFLX   289.67 (+3.10%)
S&P 500   3,941.67 (-0.40%)
DOW   33,612.22 (-0.71%)
QQQ   280.91 (+0.12%)
AAPL   141.18 (+0.01%)
MSFT   242.00 (+0.69%)
META   111.56 (+1.92%)
GOOGL   96.13 (+0.99%)
AMZN   91.85 (-0.62%)
TSLA   181.45 (+0.34%)
NVDA   157.60 (+0.77%)
NIO   12.25 (+16.67%)
BABA   87.02 (+8.97%)
AMD   73.11 (-0.38%)
T   18.94 (-0.37%)
MU   54.48 (-1.16%)
CGC   3.43 (+0.29%)
F   13.55 (-1.45%)
GE   83.53 (-2.49%)
DIS   94.32 (-0.39%)
AMC   7.11 (-4.31%)
PYPL   75.79 (-2.38%)
PFE   49.28 (-0.42%)
NFLX   289.67 (+3.10%)
S&P 500   3,941.67 (-0.40%)
DOW   33,612.22 (-0.71%)
QQQ   280.91 (+0.12%)
AAPL   141.18 (+0.01%)
MSFT   242.00 (+0.69%)
META   111.56 (+1.92%)
GOOGL   96.13 (+0.99%)
AMZN   91.85 (-0.62%)
TSLA   181.45 (+0.34%)
NVDA   157.60 (+0.77%)
NIO   12.25 (+16.67%)
BABA   87.02 (+8.97%)
AMD   73.11 (-0.38%)
T   18.94 (-0.37%)
MU   54.48 (-1.16%)
CGC   3.43 (+0.29%)
F   13.55 (-1.45%)
GE   83.53 (-2.49%)
DIS   94.32 (-0.39%)
AMC   7.11 (-4.31%)
PYPL   75.79 (-2.38%)
PFE   49.28 (-0.42%)
NFLX   289.67 (+3.10%)
S&P 500   3,941.67 (-0.40%)
DOW   33,612.22 (-0.71%)
QQQ   280.91 (+0.12%)
AAPL   141.18 (+0.01%)
MSFT   242.00 (+0.69%)
META   111.56 (+1.92%)
GOOGL   96.13 (+0.99%)
AMZN   91.85 (-0.62%)
TSLA   181.45 (+0.34%)
NVDA   157.60 (+0.77%)
NIO   12.25 (+16.67%)
BABA   87.02 (+8.97%)
AMD   73.11 (-0.38%)
T   18.94 (-0.37%)
MU   54.48 (-1.16%)
CGC   3.43 (+0.29%)
F   13.55 (-1.45%)
GE   83.53 (-2.49%)
DIS   94.32 (-0.39%)
AMC   7.11 (-4.31%)
PYPL   75.79 (-2.38%)
PFE   49.28 (-0.42%)
NFLX   289.67 (+3.10%)
NYSEAMERICAN:ISR

Isoray - ISR Stock Forecast, Price & News

$0.37
-0.01 (-3.09%)
(As of 11/30/2022 11:19 AM ET)
Add
Compare
Today's Range
$0.37
$0.37
50-Day Range
N/A
52-Week Range
$0.19
$0.51
Volume
15,200 shs
Average Volume
337,304 shs
Market Capitalization
$53.01 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

Isoray MarketRank™ Forecast

Analyst Rating
N/A
Upside/​Downside
N/A
Short Interest
Healthy
0.35% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
N/A
Insider Trading
Acquiring Shares
$34,000 Bought Last Quarter
Proj. Earnings Growth
Growing
From ($0.04) to ($0.02) Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.86 out of 5 stars

ISR stock logo

About Isoray (NYSEAMERICAN:ISR) Stock

Isoray, Inc., together with its subsidiaries, develops, manufactures, sells, and markets isotope-based medical products and devices for the treatment of cancer and other malignant diseases in the United States and internationally. The company offers CS-1 Cesium-131 brachytherapy seeds for the treatment of prostate, brain, lung, head and neck, gynecological, pelvic/abdominal, and colorectal cancers. It sells its products to facilities or physician practices that utilize various surgical facilities. Isoray, Inc. was founded in 1998 and is based in Richland, Washington.

Receive ISR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Isoray and its competitors with MarketBeat's FREE daily newsletter.

ISR Stock News Headlines

IsoRay earnings, Revenue miss in Q1 - Investing.com India
IsoRay (ISR) Reports Q4 Loss, Misses Revenue Estimates
See More Headlines
Receive ISR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Isoray and its competitors with MarketBeat's FREE daily newsletter.

ISR Company Calendar

Last Earnings
9/28/2022
Today
11/30/2022
Fiscal Year End
6/30/2023

Industry, Sector and Symbol

Industry
Surgical & Medical Instruments
Sub-Industry
N/A
Sector
Medical
Current Symbol
NYSEAMERICAN:ISR
Previous Symbol
NYSEMKT:ISR
Employees
61
Year Founded
N/A

Profitability

Net Income
$-3,390,000.00
Pretax Margin
-48.05%

Debt

Sales & Book Value

Annual Sales
$10.05 million
Book Value
$0.48 per share

Miscellaneous

Free Float
138,481,000
Market Cap
$53.01 million
Optionable
Not Optionable
Beta
0.92

Key Executives

  • Ms. Lori A. Holmes-Woods (Age 60)
    CEO & Director
    Comp: $486k
  • Ms. Jennifer Streeter (Age 52)
    COO & VP of HR
    Comp: $366.21k
  • Mr. William A. Cavanagh III (Age 56)
    Chief R&D Officer
    Comp: $325.2k
  • Mr. Jonathan R. Hunt (Age 55)
    CFO & Co-Principal Financial Officer
  • Mr. Mark J. Austin CPA (Age 35)
    VP of Fin., Controller, Co-Principal Financial, Principal Accounting Officer & Sec.
  • Ms. Krista Cline (Age 40)
    Sr. Director of Operations & Corp. Sec.













ISR Stock - Frequently Asked Questions

How have ISR shares performed in 2022?

Isoray's stock was trading at $0.38 on January 1st, 2022. Since then, ISR shares have increased by 1.3% and is now trading at $0.3849.
View the best growth stocks for 2022 here
.

Are investors shorting Isoray?

Isoray saw a decline in short interest in the month of November. As of November 15th, there was short interest totaling 496,900 shares, a decline of 28.8% from the October 31st total of 698,100 shares. Based on an average daily volume of 309,700 shares, the short-interest ratio is presently 1.6 days. Approximately 0.4% of the shares of the company are short sold.
View Isoray's Short Interest
.

How were Isoray's earnings last quarter?

Isoray, Inc. (NYSEAMERICAN:ISR) announced its quarterly earnings results on Wednesday, September, 28th. The healthcare company reported ($0.01) EPS for the quarter, hitting the consensus estimate of ($0.01). The healthcare company earned $2.51 million during the quarter, compared to analyst estimates of $2.89 million. Isoray had a negative net margin of 48.05% and a negative trailing twelve-month return on equity of 9.19%.

What other stocks do shareholders of Isoray own?
What is Isoray's stock symbol?

Isoray trades on the New York Stock Exchange (NYSE)AMERICAN under the ticker symbol "ISR."

Who are Isoray's major shareholders?

Isoray's stock is owned by many different retail and institutional investors. Top institutional investors include Perkins Capital Management Inc. (2.01%). Insiders that own company stock include Jonathan Robert Hunt, Lori A Woods, Mark John Austin, Michael Krachon and Philip J Vitale.
View institutional ownership trends
.

How do I buy shares of Isoray?

Shares of ISR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Isoray's stock price today?

One share of ISR stock can currently be purchased for approximately $0.38.

How much money does Isoray make?

Isoray (NYSEAMERICAN:ISR) has a market capitalization of $54.70 million and generates $10.05 million in revenue each year. The healthcare company earns $-3,390,000.00 in net income (profit) each year or ($0.05) on an earnings per share basis.

How can I contact Isoray?

Isoray's mailing address is 350 Hills St Ste 106, RICHLAND, WA 99354-5511, United States. The official website for the company is isoray.com. The healthcare company can be reached via phone at (509) 375-1202, via email at dbabcock@isoray.com, or via fax at 509-267-3670.

This page (NYSEAMERICAN:ISR) was last updated on 11/30/2022 by MarketBeat.com Staff